SPIKE – a database, visualization and analysis tool of cellular signaling pathways by Elkon, Ran et al.
BioMed  Central
Page 1 of 15
(page number not for citation purposes)
BMC Bioinformatics
Open Access Software
SPIKE – a database, visualization and analysis tool of cellular 
signaling pathways
Ran Elkon1, Rita Vesterman1, Nira Amit1, Igor Ulitsky2, Idan Zohar2, 
Mali Weisz1, Gilad Mass1, Nir Orlev1, Giora Sternberg1, Ran Blekhman1,3, 
Jackie Assa2, Yosef Shiloh1 and Ron Shamir*2
Address: 1The David and Inez Myers Laboratory for Genetic Research, Department of Molecular Genetics and Biochemistry, Sackler School of 
Medicine, Tel Aviv University, Tel Aviv 69978, Israel, 2School of Computer Science, Tel Aviv University, Tel Aviv 69978, Israel and 3Department 
of Human Genetics, University of Chicago, Chicago, IL 60637, USA
Email: Ran Elkon - ranel@post.tau.ac.il; Rita Vesterman - ritaves1@post.tau.ac.il; Nira Amit - amitnira@post.tau.ac.il; 
Igor Ulitsky - ulitskyi@post.tau.ac.il; Idan Zohar - idanzohar@gmail.com; Mali Weisz - mali@post.tau.ac.il; Gilad Mass - mass@post.tau.ac.il; 
Nir Orlev - nirorlev@yahoo.com; Giora Sternberg - giora.sternberg@new.ox.ac.uk; Ran Blekhman - blekhman@uchicago.edu; 
Jackie Assa - JackAssa@post.tau.ac.il; Yosef Shiloh - yossih@post.tau.ac.il; Ron Shamir* - rshamir@post.tau.ac.il
* Corresponding author    
Abstract
Background: Biological signaling pathways that govern cellular physiology form an intricate web
of tightly regulated interlocking processes. Data on these regulatory networks are accumulating at
an unprecedented pace. The assimilation, visualization and interpretation of these data have
become a major challenge in biological research, and once met, will greatly boost our ability to
understand cell functioning on a systems level.
Results: To cope with this challenge, we are developing the SPIKE knowledge-base of signaling
pathways. SPIKE contains three main software components: 1) A database (DB) of biological
signaling pathways. Carefully curated information from the literature and data from large public
sources constitute distinct tiers of the DB. 2) A visualization package that allows interactive graphic
representations of regulatory interactions stored in the DB and superposition of functional
genomic and proteomic data on the maps. 3) An algorithmic inference engine that analyzes the
networks for novel functional interplays between network components.
SPIKE is designed and implemented as a community tool and therefore provides a user-friendly
interface that allows registered users to upload data to SPIKE DB. Our vision is that the DB will be
populated by a distributed and highly collaborative effort undertaken by multiple groups in the
research community, where each group contributes data in its field of expertise.
Conclusion: The integrated capabilities of SPIKE make it a powerful platform for the analysis of
signaling networks and the integration of knowledge on such networks with omics data. 
Background
Our realization of the complexity of signaling networks
that regulate cellular physiology is growing commensu-
rate with the rapid growth in biological knowledge. It is
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now clear that biological pathways that govern cellular
development and responses to environmental challenges
are not linear, parallel and independent, but rather form
an intricate web of interlocking processes tightly control-
led by various logics of positive and negative feedback
loops [1,2]. Given this high degree of complexity, it is
essential to develop computational means for processing,
presenting and analyzing cellular signaling networks.
However, at the present time most biological knowledge
resides as free text in archives of scientific journals. Before
this knowledge can be processed by computers, it has to
be transformed into symbolic form using highly struc-
tured languages. The need to represent biological knowl-
edge in a formal language within electronic knowledge-
bases (KBs) is well recognized and several ontologies have
been defined and electronic repositories have been estab-
lished in recent years. Many of them (e.g., EcoCyc [3], WIT
[4]) focus on metabolic pathways in lower organisms,
which at present are the most characterized pathways. KBs
are also being developed for signal transduction pathways
in higher eukaryotes together with supporting network
visualization packages (e.g., KEGG [5], Reactome [6],
aMAZE [7,8], BIND [9], PATIKA [10] and CellDesigner
[11]).
Biological KBs are also becoming essential to the analysis
of data obtained by high-throughput functional genomic
and proteomic technologies. For example, when the effect
of a certain perturbation on the cellular transcriptome is
examined, hundreds of genes typically respond. One way
to understand the biological meaning of the observed
response is to systematically integrate these results with
current biological knowledge and then search for path-
ways that are significantly enriched for responding genes.
GenMapp [12], KEGG [5], and Cytoscape [13] are exam-
ples of tools that provide such capabilities in various
forms.
We are developing SPIKE (Signaling Pathway Integrated
Knowledge Engine) as a tool to help researchers integrate,
visualize, interpret and share existing and novel informa-
tion on cellular signaling networks, and to boost the bio-
logical interpretation of wide-scale 'omic' datasets. SPIKE's
DB already contains extensive and highly curated data on
signaling pathways in human cells related to DNA dam-
age and other stress responses, cell cycle checkpoints,
apoptosis, and innate immunity signaling, in addition to
data from massive screenings for human protein-protein
interaction. The main feature that distinguishes SPIKE
from other extant signaling KBs is its design and imple-
mentation as a community tool. Our vision is that the
manually curated tier of the DB will be populated by a dis-
tributed and highly collaborative effort undertaken by
multiple groups in the research community, where each
group contributes data in its field of expertise. To meet
this goal, both the modeling scheme used in SPIKE for the
representation of signaling pathways and the process of
data upload by end users are kept very simple, making
SPIKE a highly flexible and agile platform for storing,
sharing and analyzing data on cellular networks.
Implementation
Overall architecture
SPIKE is composed of three main software components:
1) A database (DB) of biological signaling pathways with
an interface that supports data uploading and querying by
multiple end-users. Carefully curated information from
the literature as well as data from large public sources con-
stitute distinct tiers of the DB. SPIKE DB is implemented
using MySQL as the DB management system (DBMS). 2)
A Java-based visualization package that allows interactive
An overview of SPIKE Figure 1
An overview of SPIKE. This scheme describes the key 
components of the system and information flow. SPIKE's 
three main software components are: 1) A DB of signaling 
pathways, containing, in distinct tiers, carefully ascertained 
information uploaded by SPIKE users and supervised by the 
curators, data from external signaling DBs (e.g., KEGG, Reac-
tome, IntAct), and wide-scale human protein-protein interac-
tion datasets [21–24]. In SPIKE's decentralized architecture, a 
copy of the DB is installed along with the software in each 
participating research lab, and these remote site DBs are 
periodically synchronized with the central DB. The informa-
tion stored in the SPIKE DB can be readily used by other 
KBs. 2) A visualization package that allows interactive repre-
sentation of selected regulatory interactions from the DB, 
dynamic layout and navigation through the displayed net-
works, and superposition of high-throughput genomic and 
proteomic data. Information displayed in the maps is linked 
to external DBs (e.g., Entrez Genes, PubMed). Prearranged 
maps for key signaling networks (e.g., p53, apoptosis, cell 
cycle, ATM, MAPK) were built and are posted at SPIKE web-
site. 3) An algorithmic engine that performs various network 
analyses, aimed at discovering novel functional interplays 
between network components.
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graphic representations of regulatory interactions stored
in the DB, dynamic layout and navigation through the
networks, and superposition of high-throughput genomic
and proteomic data on the displayed maps. 3) An algo-
rithmic inference engine that analyzes the networks for
novel functional interplays between network compo-
nents, and enhances the analysis of omic datasets (Figure
1).
Modeling scheme
SPIKE uses a formal modeling scheme in which informa-
tion on signaling pathways is summarized in a structured
language amenable to computerized manipulation and
analysis. The scheme is based upon three fundamental
requirements: First, it should be of sufficient expressive
power to capture information on most aspects of regula-
tory pathways. Second, it should focus on signaling rather
than metabolic pathways, and on the regulatory inter-
plays maintained between network components (the bio-
chemical mechanisms by which the regulatory effects are
elicited are of secondary importance in our model). Third,
the scheme should be kept simple in order to ease data
input by the SPIKE user community. Such input is crucial
as our long-term goal is to have the manually curated tier
of the DB populated primarily by the users' community.
With these considerations in mind, we adopted (using the
terminology of Kitano et al. [11]) an 'entity-relationship'
scheme over a 'state transition' one. The 'state transition'
scheme regards different post-translational modified ver-
sions of a protein as separate entities (or as different
'states' of a protein), visually represents them as distinct
nodes in the map, and seeks to trace the transition
between these states. The 'entity-relationship', on the
other hand, does not distinguish between different modi-
fied states of a protein and does not look for such state
transitions; it focuses, rather, on the regulatory effects
maintained between different proteins within a signaling
network (Figure 2A–B). In a state transition scheme
(adopted, for example, by Reactome [6], PATIKA [10],
CellDesigner [11]), representation of signaling pathways
could become extremely complex due to combinatorial
growth of possible states (for example, a protein that can
be modified on only 5 residues has 25 = 32 different
states). An entity-relationship scheme (adopted, for exam-
ple, by KEGG [5] and Kohn's maps [14,15]) is much sim-
pler, having all these states represented by only one
protein entity, but at the price of not accounting for pos-
sible temporal order constraints on the state transitions
(e.g., activation of a protein by its phosphorylation on res-
idue B can occur only after it is first phosphorylated on
residue A).
The entity-relationship scheme we designed for SPIKE is
based on two basic types of objects: "biological entities" and
"relations".
Biological entities
SPIKE's modeling scheme comprises four types of biolog-
ical entities:
a. Gene/RNA/Protein
Genes (and their respective RNA and protein products)
are the primary atomic elements of the scheme. To avoid
ambiguities, only characterized human genes that are
assigned a formal designation by the Human Genome
Nomenclature Committee (HGNC) are included in
SPIKE's gene space. These objects are uniquely identified
by their Entrez Gene IDs [16]. For simplicity, we decided
not to define distinct objects for genes, their transcribed
RNAs and translated proteins, and their modifications.
See below a discussion of scheme limitations. Non-pro-
tein coding genes (e.g., genes encoding for rRNAs, tRNAs
and microRNAs) are also included in this entity type.
b. Family
A family is a group of isoform genes (encoded by distinct
genomic loci) with high sequence homology and whose
encoded proteins share most of their biological activities.
Well known examples are the JNK family, which includes
the JNK1, JNK2 and JNK3 proteins (whose official names
are MAPK8, MAPK9 and MAPK10), and the p38 family,
which is comprised of four p38 isoforms (officially desig-
nated as MAPK11–14).
c. Complex
A complex is a group of proteins (or protein families) that
carry out a specific function only when associated with
their complex mates. An example is the DNA-damage sen-
sor MRN complex, which is composed of the proteins
MRE11, RAD50 and NBS1 [17]. The complex entity sup-
ports a nested structure, namely, a complex can be built
from sub-complexes.
d. Small molecule
This entity enables the modeling scheme to include
descriptions of regulations involving small signaling mol-
ecules such as GTP, cAMP, Ca++, etc. Signaling molecules
in SPIKE are identified using their ID in the ChEBI DB
[18].
In contrast to genes/proteins and small molecules, no
controlled nomenclature is available for designating fam-
ilies and complexes. For these entities we use the most
common name in the literature.BMC Bioinformatics 2008, 9:110 http://www.biomedcentral.com/1471-2105/9/110
Page 4 of 15
(page number not for citation purposes)
Relations
The second type of object in our modeling scheme is rela-
tions. The scheme defines three types of relations:
a. Regulation
Every regulation in SPIKE is defined by a triplet of the fol-
lowing simple form: Source, Regulatory effect, and Target.
For example, "ATM activates TP53", and "CDKN1A inhib-
its the CDK2-CCNE complex". A regulatory interaction
can be defined between any two biological entities, or
between a biological entity and another regulation. A reg-
ulation can have one of three regulatory effects: "pro-
mote/activate", "inhibit/repress", or "unknown". Each
regulation (defined by its source, target and effect) is asso-
ciated with several attributes: the biochemical mechanism
by which it is driven (e.g., phosphorylation, transcrip-
tional regulation, ubiquitination), one or more support-
ing references, quality level and status flag for quality
control (see below), and the submitter/data source.
The fact that our scheme allows one regulation as the tar-
get of another enhances its expressivity. First, it enables us
to describe regulations that affect only a subset of down-
stream regulations emanating from an entity, as illus-
trated in Figure 3A. Second, it improves the specificity of
the description, as demonstrated by the comparison
between Figure 3B and Figure 3C. For regulations that act
on other regulations, an additional attribute is added: the
physical target, which specifies the physical entity on which
the biochemical interaction is exerted (see Figure 3C).
b. Interaction
Much data exist on pairs of proteins that are known to
physically interact, but whose regulatory effect is not yet
understood. Interaction relations represent such physical
SPIKE modeling scheme Figure 2
SPIKE modeling scheme. State transition scheme vs. entity-relationship scheme. (A). The 'state transition' scheme regards 
different post-translational modified versions of a protein as separate entities (or as different 'states' of a protein), visually rep-
resents them as distinct nodes in the map, and aims at tracing the transition between these states. (B). In contrast, the 'entity-
relationship' scheme views all these entities as one protein, and focuses on the regulatory effects between different proteins 
within a signaling network. In a state transition scheme, representation of signaling pathways could become extremely complex 
due to combinatorial growth of possible states. An entity-relationship scheme is much simpler, having all these states repre-
sented by only one entity, but at the price of not taking into account temporal order constraints on the state transition reac-
tions in cases where such constraints exist.
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interactions, which, unlike regulations, are symmetrical
rather than directional. Each interaction is defined by the
two participating proteins, and has the following
attributes: the experimental method used to identify it
(e.g., Y2H, co-immunoprecipitation), supporting refer-
ence(s), quality and status flags, and the submitter/data
source.
c. Containment
This type of relation is used to define the relationship
between families/complexes and the members they con-
tain.
Limitations
SPIKE's modeling scheme is intentionally simple, facilitat-
ing easy input to the DB by many end-users. Despite its
simplicity, the scheme can describe most key aspects of
signal transduction pathways. However, at this stage it
deliberately does not account for metabolic reactions,
splice variants, cell types and cellular compartments, or
for any quantitative aspects of regulations. It also deliber-
ately avoids distinction between a gene and its RNA and
protein. SPIKE focuses on regulatory effects maintained
between components within signaling networks. We
found that for our goals it is not essential to explicitly
model the layer in which the regulatory effect is exercised
(i.e., transcriptional regulation, post-translational modifi-
cation, etc.). However, information on the specific bio-
chemical mechanism is stored in the DB, being one of the
attributes attached to each regulation. While SPIKE's mod-
eling scheme can accommodate data on any signaling
pathway from any organism, at present the implemented
DB supports data obtained only in human cells (as genes
are associated with the human Entrez-Gene ID and are
designated using their HGNC official symbol).
Despite these limitations, SPIKE's design is flexible
enough to allow its adjustment to support many of the
above features in the future, as biological knowledge
expands and standard ontologies and nomenclatures
become widely accepted.
Results
The Database
SPIKE DB contains data from three sources: 1) relations
uploaded manually by SPIKE curators and users; 2) rela-
tions imported en masse from external signaling pathway
DBs (we have already imported data from KEGG [19],
Reactome [6] and IntAct [20]). 3) Wide-scale protein-pro-
tein interaction datasets that resulted from high-through-
put screens in human cells. Currently, the datasets
reported by Stelzl et al. [21], Rual et al. [22], Lim et al [23]
and Ewing et al. [24] are incorporated. Table 1 summa-
rizes the current status of the DB.
SPIKE defines a user hierarchy of four levels: guest, user,
curator and admin. Users at the second level and above
Regulation as target of another regulation Figure 3
Regulation as target of another regulation. (A). The 
ability to define a regulation as a target of another regulation 
is helpful in cases where the effect of regulator A on target B 
is transmitted to some but not all targets of B. In this sche-
matic example, A specifically inhibits the B-mediated activa-
tion of C. (B). A schematic representation of p53 activation 
by CHK2 [31]. (C). A more specific representation: here, the 
information that the activation of p53 is achieved by CHK2 
interfering with the inhibition of p53 by MDM2 is explicitly 
represented. This interference is achieved by CHK2 phos-
phorylation of p53 [31], and therefore the 'physical target' 
attribute of this regulation is p53.
A
B
E D C
CHK2 p53
3A.  3B. 
3C. 
MDM2 p53
CHK2
A B
C
Table 1: Current status of SPIKE DB (as of November 2007).
Quality Level No. of Regulations No. of Interactions No. of Containments
1 652 7 363
21 7 0 0
3 421 0 521
4 41 21832 906
Total 1,131 21,839 1,790BMC Bioinformatics 2008, 9:110 http://www.biomedcentral.com/1471-2105/9/110
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are privileged to upload new relations to the DB (Figure
4). A privacy mechanism was implemented that allows
users to mark as 'private' entries submitted to the DB.
Such entries can be accessed only by the laboratory that
submitted them. This feature is used for including data in
the pre-publication phase. Curated data uploaded manu-
ally to date have focused mainly on pathways related to
DNA damage responses, cell cycle regulation, apoptosis,
innate immunity and stress responses. Data loaded en
masse from external KBs and high-throughput datasets
cover all aspects of cellular physiology.
The issue of data quality is addressed by several means.
First, only privileged users are allowed to upload data to
SPIKE DB. Such a privilege is granted only to labs with
established expertise in their research field. Second, each
submission is assigned a quality level and a status flag.
The quality level is set by the user who uploads the regu-
lation and reflects the reliability he/she ascribes to it; in
general, relations derived from highly focused biochemi-
cal studies are assigned high quality, while those derived
from high-throughput experiments are assigned low qual-
ity. The status flag is set to 'Draft' at the time of submis-
sion. SPIKE designated curators review all new
submissions, decide whether to accept, edit or reject them,
and set the status flag accordingly.
The current version of SPIKE employs a decentralized DB
architecture that supports automatic database synchroni-
zation. A local copy of the DB is installed along with the
software in each research lab, and these DBs are periodi-
cally synchronized with the central DB. A detailed descrip-
tion of SPIKE DB synchronization mechanism is provided
in Appendix A. Having local installation of SPIKE DB
ensures a genuine and full support for private data. Data
are exchanged between the local and central DBs using the
SPIKE XML schema that we defined for this purpose
(Appendix C). Additionally, the SPIKE XML serves as the
primary import/export format in which all the informa-
tion stored in the SPIKE DB is available. Consequently,
this information can be electronically manipulated by any
interested party and may be readily incorporated into
other external KBs. To facilitate data exchange, we imple-
mented a program that converts SPIKE data to the stand-
ard BioPAX format (BioPAX level 2 [25]). The content of
SPIKE DB is available in this format from our website.
However, due to differences in the representation, BioPaX
cannot fully convey all the information stored in SPIKE
XML.
The visualization module
The pathway visualization module allows dynamic net-
work representation of selected biological data stored in
the DB and gradual navigation through it. Researchers can
manipulate the network map interactively, control its lay-
out, expand or collapse selected segments, and retrieve
further information on both biological entities and regu-
lations. SPIKE's four types of biological entities are dis-
played in the maps using nodes of different colors (Figure
5). Although the modeling scheme does not distinguish
between a gene and its RNA and protein products, given
the growing data on regulatory roles played by microR-
NAs in various signaling pathways, protein-coding and
non-coding genes are displayed using different colors. The
three types of relations (regulations, interactions and con-
tainments) are denoted by distinct types of edges (Figure
5).
Salient features implemented in SPIKE's visualization
module include:
• Dynamic navigation and expansion of maps. Double
clicking on a node leads to the addition to the map of all
Adding new information to SPIKE DB Figure 4
Adding new information to SPIKE DB. Submission 
forms allow privileged users to upload data to the DB. Here, 
the form for submission of a new regulation is shown. The 
user specifies the source, target and effect of the regulation. 
Additional regulation attributes include the biochemical 
mechanism, one or more supporting references, the submit-
ter, and the quality level ascribed to the data. Submitted data 
can be flagged as private, in which case the data will be visible 
only to the user who uploaded it.BMC Bioinformatics 2008, 9:110 http://www.biomedcentral.com/1471-2105/9/110
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its direct neighbors meeting the quality-level threshold set
by the user.
• Retrieving further information on genes and regulations.
Clicking on a gene's pop-up menu opens its Entrez-Gene
web page. Clicking on an edge's pop-up menu allows
opening abstracts of the supporting citations from
PubMed. In addition, a properties description panel dis-
plays more details about each object, in addition to the
information supplied in the map itself (e.g., status, quality
and submitter data for regulations; full official designa-
tion and description for nodes).
• Data filtering. A filtering mechanism allows users to dis-
play only data filtered according to different parameters,
such as status flag, quality level, data source, and data
owner.
• Graph layout. Automatic and manual layout mecha-
nisms can be used to facilitate organization of the maps.
Edges can also be moved and manipulated by the user to
improve the layout of the map.
• A 'recycling bin' enables users to temporarily hide spe-
cific nodes and edges in order to improve clarity of the dis-
played maps.
• Superposition of omics data on the maps. This utility
facilitates the biological interpretation of microarray and
other high-throughput measurements. For example,
SPIKE visualization of signaling networks Figure 5
SPIKE visualization of signaling networks. The different types of biological entities are represented in SPIKE maps by 
nodes of different colors: violet nodes correspond to protein-coding genes, turquoise nodes to non protein-coding genes (e.g., 
micro-RNAs, rRNAs, tRNAs), green nodes to protein complexes, and yellow nodes to protein families. Small molecules are 
displayed in orange (not included in this map). Blue directed edges represent regulations: arrows correspond to activation, T 
shape edges to inhibition, and open circles denote regulations whose effect is still not clear (e.g., ATM was reported to phos-
phorylate MCM2, but the effect of this modification is not known yet). Blue undirected edges represent protein-protein inter-
actions (not included in this map). Green edges represent containment relations between nodes (e.g., a complex and its 
components). Red and green dots within a node indicate that not all regulation and containment relations stored in the DB for 
the node are displayed in the map. This map represents the ATM-regulated network which is set off by the cell in response to 
double-strand breaks in the DNA.BMC Bioinformatics 2008, 9:110 http://www.biomedcentral.com/1471-2105/9/110
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coloring maps according to gene expression levels might
point to pathways that are active in the analyzed dataset
(Figure 6). SPIKE's node coloring mechanism is very flex-
ible and allows the coloring of nodes according to any
node partition defined by the user (e.g., GO categories or
clustering results).
• Maps built and laid out by the user can be saved and
reloaded for further analysis and manipulation. The map
files are saved using the SPIKE XML format. This also
allows exchange of detailed signaling maps among SPIKE
users.
We have built network maps for several key cellular sign-
aling networks, including maps for the p53 and ATM net-
works, cell cycle, apoptosis, and MAPK and TLR signaling.
The maps are posted on the SPIKE website. Importantly,
these are not static maps: they are linked to the SPIKE DB,
so when loaded by the user they can be further expanded
(by double-clicking on selected nodes). In addition,
Superposition of 'omics' data on maps Figure 6
Superposition of 'omics' data on maps. By allowing the user to superimpose functional genomic or proteomic data on 
pathway maps, SPIKE facilitates improved interpretation of such datasets. The color of the bar above each gene's node indi-
cates its response. Upregulated genes are shades of red: the darker the red the greater the fold of induction. Similarly, down-
regulated genes are in shades of green. Genes whose expression was not changed are yellow, and genes for which data are not 
available (e.g., genes not present on the microarray) are grey. In this example, superimposing gene expression data measured in 
human lymphocyte cells exposed to ionizing radiation on the signaling map shows the activation of the p53 network (top-left 
part of the network) and the down-regulation of genes that function in the cell cycle G2-M phase transition (bottom-right part 
of the network). Superimposing the data on this map clearly shows that a large fraction of the p53 network was activated in the 
analyzed condition. SPIKE also allows superimposition of clustering data: any partition of the genes into groups (e.g., according 
to GO annotation, cellular compartment, clustering, or user-specific definitions) can be viewed on the pathway map. The color 
scheme can be adjusted by the user.BMC Bioinformatics 2008, 9:110 http://www.biomedcentral.com/1471-2105/9/110
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updates to the DB are automatically reflected in the map
(the existence of new regulations that involve any node in
the map and that are not displayed in it will be indicated
by a red dot within the node). This ensures that the maps
posted on the site are continuously synchronized with the
DB. SPIKE users can join the collaborative effort, building
signaling maps for pathways that are in the focus of their
research, and contributing these maps to the community
by posting them on the SPIKE web site.
The algorithmic engine
SPIKE's algorithmic engine is designed to include various
graph-theory algorithms that analyze the network, charac-
terize its topological properties, integrate omics  data to
identify functional modules in the network, and suggest
novel regulatory interplays between components. At
present, we have implemented three basic utilities:
• Path finding
This utility finds and displays all direct paths, up to a pre-
defined maximal length, that connect source and target
nodes specified by the user (Figure 7). This utility sup-
ports also undirected edges (interactions). However, by
default, undirected edges are excluded from this analysis
as such links are much less informative than directed
ones. The user can choose whether to include or exclude
interactions (which are usually of lower quality level than
the regulations in SPIKE DB).
• Interconnections within a set of genes/proteins
Given target sets of genes/proteins provided by the user
(e.g., gene clusters identified by analysis of gene expres-
sion data), this utility displays all the direct connections
among nodes within each set (with an option to allow
connection via a single intermediate node not included in
the input set) (Figure 8).
• Enriched maps
Given target sets of genes/proteins uploaded by the user,
the utility searches for signaling maps enriched for nodes
included in one of the target sets. Enrichment scores are
calculated using the hypergeometric distribution and are
computed with respect to a given background set (e.g., all
the genes present on a microarray platform). Maps that
are significantly enriched (beyond a specified p-value
threshold) are listed in the results table. Clicking on a
map's link in this table opens the enriched map, in which
target set nodes are highlighted (Figure 9).
Installation
SPIKE can be downloaded from [26]. It has two modes of
installation: a stand-alone tool (evaluation mode) and a
community tool (standard mode). Installing the evalua-
tion mode (which is based on the Java Web-Start technol-
ogy) is straightforward: It requires the execution of a
single file, and installation is completed by a few clicks. It
also provides a mechanism for automatic software
upgrades and maintenance. This installation is currently
limited to Microsoft Windows 2000/XP OS and requires
ad-hoc procedures for synchronization of data with the
central SPIKE DB.
A research group that wishes to join the SPIKE community
should fill-in an online form available at SPIKE website
and have the tool locally installed in its "standard instal-
lation" mode. The standard mode of installation grants
the user full functionality of the tool. Mainly, it supports
synchronization between the site and the central DB and
can serve several users on different machines within one
internal network site (typically, several users within a
research lab and several research labs in the same insti-
tute). It requires installation of the MySQL DB server on
one machine on the site. Detailed installation instructions
are provided on the website. This installation mode
allows data submitted at the site to be shared with the
entire SPIKE community (while retaining the option to
hide some private data), and enables that site to benefit
Path finding Figure 7
Path finding. The user specifies the source, the target and 
the maximal number of edges in a path connecting them. By 
default, un-directed edges (that is, protein-protein interac-
tions) are excluded from the analysis. In this example, path-
ways linking ATM to CASP3, a major effector of apoptosis, 
are sought. All paths that meet the length constraint are dis-
played with the shortest paths highlighted.BMC Bioinformatics 2008, 9:110 http://www.biomedcentral.com/1471-2105/9/110
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from the data submitted by other sites. The standard
installation supports Windows, UNIX and Mac OS.
Conclusion
SPIKE provides the research community with a powerful
integrated KB of signaling pathways in human cells. The
tool helps researchers integrate, visualize and interpret
existing and novel information on cellular networks. It
can be of great utility both for labs whose research is
focused on specific processes and networks (e.g., p53 net-
work), and for 'omics' labs that strive for comprehensive,
systems-level delineation of cell functioning.
Gene/protein-centric labs can utilize SPIKE as a central
repository for regulations and interactions involving
genes, proteins and processes that are in the focus of their
research, and greatly benefit from data uploaded by other
labs in the same research field. As a pilot case, at present
we are focusing our curation effort on signaling pathways
that are induced by DNA damage (including DNA repair,
cell cycle checkpoints, cell death and general stress
responses), and are building a community of SPIKE users
in the DNA damage research field. Any biologist in this
community can find SPIKE very useful in addressing sim-
ple queries such as 'which proteins are directly regulated
by p53?', 'is there a pathway that connects two genes
whose knockdown results in a similar hyper-sensitivity to
DNA damage?'. In parallel, we encourage and support the
establishment of additional sub-communities that cover
other aspects of cellular physiology.
Labs that carry out wide-scale 'omics' experiments can uti-
lize SPIKE's analytic and visualization features to mine
meaningful biological hypotheses out of the data (e.g., by
Interconnections within a set of genes/proteins Figure 8
Interconnections within a set of genes/proteins. Interconnections among nodes within a specified target set of genes or 
proteins (e.g., sets obtained by cluster analysis applied to gene expression microarray data) are displayed. This figure shows the 
interconnections within a cluster of genes that were induced by LPS treatment, including single intermediate nodes not con-
tained in the original cluster. Nodes corresponding to genes contained in the input cluster are highlighted in pink.BMC Bioinformatics 2008, 9:110 http://www.biomedcentral.com/1471-2105/9/110
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using map enrichment tests or the interconnection util-
ity), and present them in lucid, aesthetic network graphs.
The flexible coloring schemes implemented in SPIKE
make it very powerful for this task. For example, using
SPIKE we built network maps in which gene nodes were
colored according to the kinetics in which they were
induced in the dataset that we analyzed and according to
regulatory-elements that we identified in their promoter
regions [27,28].
SPIKE is under continuous development and we plan to
enhance several functionalities in future versions. It will
be upgraded to a web-based system that will enable its use
over the web without local installation. It will be devel-
oped into a multiple-species KB. Visualization capabilities
will be enhanced by adding hierarchical and other graph
layout mechanisms. We are currently implementing an
interface between SPIKE and our EXPANDER package for
analysis of microarray data [29] aimed at creating one
streamlined process for handling such data, beginning in
the very early preprocessing stage of data-normalization
and ending with integrating the results with knowledge
on signaling networks. We are also using high-throughput
results to develop algorithms for the identification of
'connected modules' and 'hot-spots' in the network (for
example, identification of sub-regions that are signifi-
cantly dense in genes/proteins that show some property of
interest, see for example our recent work [30]). In parallel,
we will continue to populate the SPIKE DB, supervise its
quality, and build additional maps for pivotal signaling
pathways.
Availability and requirements
Project name: SPIKE
• Project home page: http://www.cs.tau.ac.il/~spike
Enriched maps Figure 9
Enriched maps. Signaling maps enriched for nodes included in target sets of genes/proteins are sought. Maps that are signifi-
cantly enriched (beyond a specified p-value threshold) are listed on the results table. Clicking on a map's link in this table opens 
the enriched map, in which nodes contained in the original input set are highlighted.BMC Bioinformatics 2008, 9:110 http://www.biomedcentral.com/1471-2105/9/110
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• Operating system(s): Windows, UNIX or Mac.
• Programming language: Java
• Other requirements: Java 1.4 or higher, MySQL DB
server
• License: free for non-commercial users
•  Any restrictions to use by non-academics: license
needed
Authors' contributions
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the system architecture, wrote the code and tested it. NO,
GS and RB implemented an earlier version of the system.
RE also populated the database and performed beta test-
ing. GM and MW are the principal curators of SPIKE. All
the authors have read and approved the final version of
the manuscript.
Appendix A – DB synchronization
SPIKE's DB synchronization module makes it possible for
remote sites to receive and send updates from/to the cen-
tral DB. Below we describe the logic of DB synchroniza-
tion as implemented for remote sites and for the central
site.
A snapshot of the central DB saved in XML format on the
SPIKE web site, and is updated periodically. Upon initia-
tion of the synchronization process at the remote site,
SPIKE downloads the latest version of the central DB from
the web site and compares it with the local DB. All entities
in the SPIKE DB are tagged with an internal accession ID.
This ID is unique, yet it is possible that the same object
will temporarily have different accession IDs in different
DBs (e.g., the same regulation was defined by several users
at different sites). Therefore, objects in the central snap-
shot that match those present in the remote DB are first
sought using SPIKE accession ID, and then by searching
for objects with identical defining components. For exam-
ple: families and complexes are defined by the set of their
genes/proteins  members; a regulation is defined by its
source, target and effect.
The synchronization process first handles entities and
relations that are present in both the local and central
DBs, starting with matching biological entities and proceed-
ing to matching relations. The tool identifies differences
between matching objects (such as: the quality level of a
regulation was changed at the central site; a supporting
reference for a regulation was added at the remote site; a
member of a family was deleted at the central site) and
handles these differences by the following logic: Each DB
change that is applied by a remote site is attached with a
change-id, and for each remote site there is a record (last-
review-change-id) for the last change that was already
reviewed by a curator at the central site. Then, if an object
that is present in both DBs is attached with a change-id that
is smaller than the last-review-change-id  (meaning that
either the object was changed by the central or other
remote sites, or that a change done by the remote site was
rejected by the central site), then the object's version of the
central DB prevails and overwrites the local version. Oth-
erwise (change-id is higher than the last-review-change-id),
the local version of the object prevails and remains as is.
Following the handling of objects that are present in both
DBs, the procedure handles objects that exist in only one
of them: objects that exist only in the local DB remain as
they are and objects that exist only in the central snapshot
are added to the local DB. At the end of the synchroniza-
tion process, the application provides the user with a sum-
mery of the updates made to the local database and
creates an XML snapshot of it, which is sent to SPIKE cen-
tral site. Importantly, data uploaded at the remote site and
flagged as private are excluded from the snapshot, ensur-
ing the confidentiality of such data. A curator at the cen-
tral site will review the snapshot sent by a remote site and
integrate it into the central DB.
The logic of DB synchronization carried out at the central
site is similar to the one of the remote sites with the major
difference that while at remote sites local DB changes due
to synchronization are exerted automatically, at the cen-
tral site all DB changes are presented to and manually
reviewed by a curator (Additional file 1). These changes
include differences between objects that are present in
both DBs and whose remote change-id is higher than the
last-review-change-id of that remote site, or objects found
only in the remote DB. The curator examines these differ-
ences and decides which to approve (possibly after some
editing) and which to reject. A decision to reject may
involve a discussion with the author of the change in
order to understand the cause of disagreement. The status
flag of changes approved by the curator is set from draft to
approved. The central database is updated by the applica-
tion according to the curator's decisions. When the update
is completed, the last-review-change-id  parameter of the
corresponding remote site is updated, and a new snapshot
of the central database is posted on the web site in XML
format.
We have thoroughly tested the synchronization module
and implemented an automatic benchmarking suit that
examines proper functionality of the module both at
remote and the central sites under different DB change
scenarios (See Appendix B). A typical DB synchronizationBMC Bioinformatics 2008, 9:110 http://www.biomedcentral.com/1471-2105/9/110
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takes approximately 5 minutes on a PC with at least 0.5
GB RAM.
Appendix B – Benchmarking of DB 
synchronization
We have implemented an automatic benchmarking suit
that examines proper functionality of the DB synchroniza-
tion module both at remote and the central sites under
different DB change scenarios as listed below.
Remote side
The tested scenarios for the remote site are:
1. Addition of a group by the remote-site – should not be
affected by synchronization
2. Deletion of a group by Central – should be removed
from the remote site after synchronization
3. Addition of a group by central – should be added to the
remote site after synchronization
4. Editing of an existing group locally – should not be
affected by synchronization
5. Editing of an existing group by Central – should be
updated at the remote site after synchronization
6. Editing of an existing group both locally and by Central
– should not be affected by synchronization
7. Same tests for regulations and interactions.
Central side
The tested scenarios for the central site are (the tests
assume that the curator approved the change exerted by
the remote site):
1. A group deleted at the central site still exists in the
remote site – the group should not be restored by synchro-
nization
2. Addition of a group by Central – should not be affected
by synchronization
3. Addition of a group by the remote site – should be
added to the central site after synchronization
4. Editing of an existing group by the remote site – should
be updated at the central site after synchronization
5. Editing of an existing group by Central – should not be
affected by synchronization
6. Editing of an existing group both by a remote site and
by Central – should accept remote changes
7. same tests for regulations and interactions
Appendix C – SPIKE XML
As the information stored in the SPIKE database is funda-
mentally different from that stored in reaction-based data-
base, the widely accepted BioPax and SBML formats were
not found to be suitable for conveying SPIKE pathways.
We thus developed a specialized XML schema for describ-
ing a SPIKE pathway. Importantly, the same XML format
is used for all communications between SPIKE sites and
for storing pathway maps. Also, the format is extremely
simple and can be easily used for converting information
to and from other formats. Examples of XML files can be
found on the SPIKE website (see Availability and require-
ments section for url, follow the Maps link therein).
On the top level of the XML, <SpikeDatabase> conveys
general information on the version of the database from
which the pathways were extracted. On the next level the
following information is encapsulated into three blocks:
• <SiteBlock> contains information about SPIKE sites,
intended for internal use of SPIKE. Each site is represented
by a single <Site> tag
• <BuildingBlock> contains information about the basic
entities in SPIKE.
• <RegulationBlock> contains information about the reg-
ulations contained in the pathway.
• <InteractionBlock> contains information about the
interactions contained in the pathway.
The <BuildingBlock> contains entities referring to single
genes/proteins or gene/protein groups:
• A <Gene> entity refers to a gene/protein and is linked to
an EntrezGene identifier through an <XRef> tag. Informa-
tion about the graphical properties of an entity, its
description and aliases are given in the <Display>,
<Description> and <Alias> tags, respectively.
• A <Group> entity contains information about the two
groupings supported by SPIKE: complexes and families.
These two groupings are distinguished by the type
attribute of the entity. The members of the group are
described in <Member> entities, each referring to an iden-
tifier of another entity from the <BuildingBlock>.
The <RegulationBlock> contains <Regulation> entities
describing regulations within the pathway. Recall that reg-BMC Bioinformatics 2008, 9:110 http://www.biomedcentral.com/1471-2105/9/110
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ulations in SPIKE are directed events (e.g., A activates/
inhibits B) as opposed to mere interactions (which are
found in the <InteractionBlock>). The constituents of the
regulation are referred to by the <Source>, <Target> and
<PhysicalTarget> entities. Note that while the target of a
regulation can be any entity from the <BuildingBlock> or
from the <RegulationBlock>, the physical target and the
source are always entities from the <BuildingBlock>. Lit-
erature support for each regulation entity is given in a
<Reference> entity.
The <InteractionBlock> is generally similar to the <Regu-
lationBlock>. It consists of <Interaction> entities,
describing an undirected connection between a pair of
entities from the <BuildingBlock>, which are referred to
by the <ProteinA> and <ProteinB> entities.
As an example, below we give SPIKE XML statements for
the three cartoon cases shown in Figures 3A–3C. For clar-
ity, we include only the core parts of SPIKE XML format
and leave out additional attributes, such as links to other
databases, visual settings and information on the source
and quality level of the regulations.
Figure 3A:
<Regulation id="B→C">
<Source ref="B"/>
<Target ref=" C"/>
<PhysicalTarget ref="C"/>
</Regulation>
<Regulation id="B→D">
<Source ref="B"/>
<Target ref=" D"/>
<PhysicalTarget ref="D"/>
</Regulation>
<Regulation id="B→E">
<Source ref="B"/>
<Target ref="E"/>
<PhysicalTarget ref="E"/>
</Regulation>
<Regulation id="A--| (B→C)">
<Source ref="A"/>
<Target ref="B→C"/>
<PhysicalTarget ref="B"/>
</Regulation>
Figure 3B:
<Regulation id="CHK2--| p53">
<Source ref="CHK2"/>
<Target ref=" p53"/>
<PhysicalTarget ref=" p53"/>
</Regulation>
Figure 3C:
<Regulation id="MDM2--| p53">
<Source ref=" MDM2"/>
<Target ref=" p53"/>
<PhysicalTarget ref=" p53"/>
</Regulation>
<Regulation id="CHK2--| (MDM2--| p53)">
<Source ref="CHK2"/>
<Target ref="MDM2--| p53"/>
<PhysicalTarget ref="p53"/>
</Regulation>
Additional material
Additional file 1
Curator's report for DB synchronization. When synchronizing the cen-
tral DB with a snapshot of a remote site DB, all DB differences are 
reported to the curator at the central site in such a report table. The curator 
manually reviews it and decides which changes to accept and which to 
reject.
Click here for file
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